Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-040255
Filing Date
2024-09-12
Accepted
2024-09-12 17:16:01
Documents
105
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nkgn-20240630.htm   iXBRL 10-Q 2123504
2 EX-31.1 nkgenbiotechinc-exhibit3113.htm EX-31.1 8369
3 EX-31.2 nkgenbiotechinc-exhibit3123.htm EX-31.2 8403
4 EX-32.1 nkgenbiotechinc-exhibit3212.htm EX-32.1 7100
  Complete submission text file 0001628280-24-040255.txt   11749206

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nkgn-20240630.xsd EX-101.SCH 99724
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nkgn-20240630_cal.xml EX-101.CAL 74364
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nkgn-20240630_def.xml EX-101.DEF 653395
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nkgn-20240630_lab.xml EX-101.LAB 821591
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nkgn-20240630_pre.xml EX-101.PRE 788793
108 EXTRACTED XBRL INSTANCE DOCUMENT nkgn-20240630_htm.xml XML 1725807
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40427 | Film No.: 241295765
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)